👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Vaccine hopes drive stocks higher on 'Black Monday' anniversary

Published 2020-10-18, 08:48 p/m
© Reuters. FILE PHOTO: A passersby wearing a protective face mask walks in front of a stock quotation board, amid the coronavirus disease (COVID-19) outbreak, in Tokyo
EUR/USD
-
XAU/USD
-
DJI
-
PFE
-
GC
-
LCO
-
CL
-
MIAPJ0000PUS
-
STOXX50
-
ILS/UAH
-

By Thyagaraju Adinarayan

LONDON (Reuters) - World stocks inched higher and the dollar slipped on Monday as rising hopes of a coronavirus vaccine by the end of the year and a U.S. fiscal package before elections offset concern over record daily infections in Europe.

Wall Street futures rose 0.8% on the 33rd anniversary of the 1987 "Black Monday" crash, when the Dow Jones Industrial Average (DJI) lost 22.6% in one day, equivalent to a drop of about 6,500 points in the index today.

The European blue-chip stocks index (STOXX50) was slightly positive even as new COVID-19 cases were growing at a record 150,000 a day in Europe. Parts of the UK were put into lockdown and France imposed curfews.

"I think there is a heady cocktail of vaccine optimism, good Asian data and a lack of full scale lockdowns which is helping the sentiment," said John Woolfitt, director of trading at Atlantic Capital Markets.

Trading volumes in Europe were however sharply lower due to a technical glitch at exchange operator Euronext, which led to trading activity being halted in Amsterdam, Brussels, Lisbon and Paris bourses.

Second wave worries and no breakthrough in the Brexit stalemate failed to curb risk appetite among investors, after U.S. House Speaker Nancy Pelosi said on Sunday she was optimistic about a coronavirus relief deal before Election Day.

"We’re not downgrading our economic forecasts due to the second wave and we believe markets shouldn’t be disappointed too as a second wave was expected," said Jeffrey Sacks, investment strategist at Citi Private Bank.

"The sharp economic recovery we saw in the latter part of the second quarter and early third is easing now."

Sacks however believes the slowdown in recovery will not affect markets due to continued monetary and fiscal support from central banks and governments. He remains "overweight" equities.

Boosting overall sentiment, drugmaker Pfizer Inc (N:PFE) said on Friday it could have a coronavirus vaccine ready in the United States by the end of this year.

Investors also took comfort from China's economic recovery in the third quarter as consumers shook off their coronavirus caution, although the weaker-than-expected headline growth capped stock market gains in Asia.

MSCI's broadest index of Asia-Pacific shares outside Japan (MIAPJ0000PUS) rose 0.5% for a second straight day of gains, paring back following third-quarter gross domestic product data from China.

Meanwhile, separate monthly indicators pointed to an expansion in economic activity in China. Industrial output accelerated 6.9% in September from a year earlier, when analysts were looking for a 5.8% gain from a 5.6% rise in August.

In currency markets, the yuan soaring to a fresh 1-1/2-year high against the dollar, while the U.S. dollar (=USD) slipped 0.3% to 93.415 against a basket of six major currencies. [USD/]

The euro (EUR=) meanwhile traded 0.3% higher at $1.1756 and the sterling rallied back to near $1.30 levels against the dollar low on Monday. Investors cut their holdings as British and European negotiators tried to salvage post-Brexit trade talks.

"EU-UK trade talks are flirting with collapse," ANZ economists said.

"UK Prime Minister Johnson said the UK needs to prepare for a no-deal outcome, as both sides cannot agree on a Canada-style FTA. Talks resume in London on Monday, but without the political willingness to shift ground, there is little the negotiators can achieve."

In commodities, Brent crude futures (LCOc1) slipped 24 cents to $42.69 a barrel and U.S. West Texas Intermediate crude futures (CLC1) traded 0.6% lower at $40.64 a barrel.

Spot gold rose 0.7% to $1,912.6 an ounce.

© Reuters. Traders are seen at work at Northern Trust offices in London

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.